Grants for Public housing authorities - Health

This grant provides funding to support postdoctoral researchers from underrepresented backgrounds in transitioning to independent cancer research roles, with a focus on clinical trials and addressing cancer health disparities.

The purpose of this Funding Opportunity Announcement (FOA) is to encourage pilot and/or feasibility research in the following areas: 1) the development and pilot testing of new or adapted interventions to prevent or delay the initiation of substance use and/or the progression from use to misuse or disorder and 2) pre-trial feasibility and acceptability testing of services and service system research relevant to the prevention of substance use. In addition to the prevention of substance use, misuse and disorder, other outcomes of interest for the research supported through FOA include a reduction in negative sequalae such as deaths related to impaired driving, suicidal behavior (e.g., nonfatal and fatal attempts), and drug- or alcohol-related acquisition or transmission of HIV infection and viral hepatitis among diverse populations and settings.

This grant provides funding to institutions and organizations for establishing a centralized data coordination center that will manage and share research data on how socioenvironmental factors influence neurocognitive development and addiction risk.

This funding opportunity supports multi-site clinical trials for innovative treatments and interventions aimed at preventing or alleviating symptoms of Alzheimer's disease and related dementias, inviting applications from a diverse range of organizations and institutions.

This funding opportunity supports innovative research projects aimed at developing tools and treatments for diagnosing and mitigating injuries from radiation exposure during public health emergencies.

This funding opportunity announcement (FOA) encourages innovative research to develop, characterize, and improve animal models, biological materials, and novel technologies to better understand human health and disease. This FOA also seeks projects aimed at improving the diagnosis and control of diseases that interfere with animal use for biomedical research. The proposed project must have broad application to multiple NIH Institutes or Centers (ICs) to align with the Office of Research Infrastructure Programs (ORIP) trans-NIH mission. The proposed studies must explore multiple body systems or evaluate diseases that impact multiple body systems. Applications that develop models focused on a specific disease or area of research, or only propose studies primarily relevant to a single NIH IC will be considered not acceptable to this FOA.

The "Single Source: NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network" grant is a $3.8 million funding opportunity from the National Institutes of Health, specifically for Queen’s University at Kingston, to support its collaboration with the U.S. in conducting large-scale, multi-site clinical trials for innovative cancer treatments, while ensuring regulatory compliance and efficient data management.

The "Development and Validation of Human Cellular Models for Alzheimer's Disease-Related Dementias (ADRD)" grant aims to fund the creation and testing of new, complex human cell models that accurately represent Alzheimer's and related dementias, with the goal of improving our understanding of these diseases and aiding in the development of potential therapies.

This grant provides funding for educational programs that improve the skills and knowledge of researchers analyzing large, complex datasets related to brain function, behavior, and social factors affecting health outcomes.

This funding opportunity supports research that develops innovative tools to measure and enhance children's language development, particularly by engaging diverse communities and understanding environmental influences.

This funding opportunity provides financial support for researchers developing innovative, non-opioid treatments for various types of pain, with a focus on early-stage studies and collaboration with underrepresented populations.

Grant Title: New Therapeutic Strategies for Genital Herpes (R21/R33 Clinical Trial Not Allowed) aims to fund innovative research to develop new treatments for genital herpes that can reduce viral shedding, prevent lesions, and lower transmission risks.

This funding opportunity supports early-stage research projects aimed at discovering new pain management targets within specific proteins, encouraging innovative approaches to develop non-addictive therapies for pain relief.

This funding opportunity provides financial support to organizations delivering legal services to homeless veterans and those at risk of homelessness, helping them overcome legal barriers to housing stability.

The "Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services" grant aims to fund research that develops and tests new strategies for combining primary care, HIV, Hepatitis, and substance use disorder prevention and treatment services to improve health outcomes for individuals at high risk for or living with these conditions in the US.

This funding opportunity supports researchers in conducting early-stage clinical trials for innovative treatments and interventions targeting neurological disorders.

This funding opportunity provides financial support for early-stage researchers from diverse backgrounds to conduct independent studies on communication disorders, including hearing and speech issues, with a focus on addressing significant scientific and clinical challenges.

This funding opportunity provides financial support to organizations working with the Eswatini government to strengthen public health systems for monitoring and responding to HIV, TB, and related health threats.

This funding opportunity is designed to support research initiatives that will study and track the long-term effects of severe viral respiratory infections in young children, aiming to improve their health outcomes as they grow.

This funding opportunity supports researchers in developing small molecule chemical probes to investigate biological processes related to mental health, aging, drug addiction, and eye diseases.